Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | 47,250 | reported | 11 May 2026 | tx 1+47,250 |
| Edgewise Therapeutics, Inc. | 45,150 | reported | 19 Nov 2025 | tx 1+45,150 |
| Oruka Therapeutics, Inc. | 35,000 | reported | 11 Dec 2025 | tx 1+35,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 47,250 | 0.00 USD | deriv |
| 11 Dec 2025 | GRANT_AWARD | Oruka Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 19 Nov 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 45,150 | 0.00 USD | deriv |